Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02796716 · ClinicalTrials.gov registry record
Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections
A clinical trial, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- 2,102
- Enrollment target
NCT02796716: Completed study, sponsored by Denver Health and Hospital Authority.
NCT02796716 is a clinical trial that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 2,102 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02796716 has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- 2,102 participants
- Enrollment target
Study Summary
This research will test a new ultra-rapid technology (called ID/AST Accelerate system) that uses a digital microscope to identify bacteria based on their growth patterns. This method does not have to wait for bacteria to grow in a lab. The new method can identify the type of bacteria within 2 hours of receiving a specimen. The new method also shows the effect of selected antibiotics on the bacteria including multidrug resistant bacteria so that doctors know within 6 hours from specimen collection which antibiotic kills the bacteria. To check the accuracy, speed and impact of the new method on antibiotic prescribing, investigators are proposing a study with two parts; The first part will test the accuracy and speed of the results obtained by the new method. The second part will test if having the results from the new method early would change the antibiotics prescribed to a patient in a simulation experiment. An independent infectious disease physician will be shown the results from the new method and asked if the results were accurate, would it change the antibiotic treatment for the patient.
Primary Outcome
Antibiotic use from the time of specimen collection until antibiotic susceptibility testing results are available to treating clinicians. Antibiotic use will be measured in days of therapy (DOT). DOT in usual care and simulated ID/AST Accelerate system will be compared
Interventions
- DEVICE Testing on new technology called Accelerate ID/AST system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,102 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-12 |
What the finished NCT02796716 record still lists
NCT02796716 is an observational study that tracks outcomes without assigning an intervention. Its 2,102 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Testing on new technology called Accelerate ID/AST system is the first listed.
NCT02796716 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02796716 about?
NCT02796716 is a clinical study titled "Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections". This research will test a new ultra-rapid technology (called ID/AST Accelerate system) that uses a digital microscope to identify bacteria based on their growth patterns. This method does not have to wait for bacteria to grow in a lab. The new method can identify the type of bacteria within 2 hours ...
What is the current status of trial NCT02796716?
This trial is currently completed. The enrollment target is 2,102 participants. The study started on 2015-07. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02796716?
The interventions under investigation include: Testing on new technology called Accelerate ID/AST system (DEVICE).
Who is sponsoring clinical trial NCT02796716?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04649242 · 2,100 participants · Phase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- NCT05206331 · 2,100 participants · Phase 4
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
- NCT05270499 · 2,100 participants
Aveir VR Real-World Evidence Post-Approval Study
- NCT06324981 · 2,100 participants · NA
Using AI Text Messaging to Improve AHA's Life's Essential 8 Health Behaviors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia